Elliptic Laboratories ASA (OSL:ELABS)
Norway · Delayed Price · Currency is NOK 3.725
-0.130 (-3.37%)
Sep 14, 2026, 4:25 PM CET
Elliptic Laboratories ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 79.89 | 101.31 | 131.91 | 68.32 | 52.06 | 54.6 |
Other Revenue | 0 | - | -0 | - | - | - |
| 79.89 | 101.31 | 131.91 | 68.32 | 52.06 | 54.6 | |
Revenue Growth | -37.10% | -23.20% | 93.08% | 31.23% | -4.64% | 80.70% |
Cost of Revenue | 84.84 | 90.44 | 87.86 | 80.55 | 62.8 | 50.81 |
Gross Profit | -4.95 | 10.87 | 44.05 | -12.23 | -10.74 | 3.79 |
Selling, General & Admin | 1.32 | 1.55 | 1.84 | 1.7 | 0.97 | 0.73 |
Other Operating Expenses | 25.57 | 24.1 | 17.09 | 19.73 | 19.11 | 5.89 |
Operating Expenses | 61.06 | 58.11 | 39.34 | 37.66 | 31.39 | 14.93 |
Operating Income | -66.01 | -47.24 | 4.71 | -49.89 | -42.13 | -11.14 |
Interest Expense | - | -1.54 | -1.84 | -1.95 | -1.24 | -1.2 |
Interest & Investment Income | 10.16 | 1.99 | 4.37 | 4.64 | 2.24 | 0.35 |
Currency Exchange Gain (Loss) | -12.67 | -12.67 | 10.35 | 0.67 | 3.29 | -0.85 |
Other Non Operating Income (Expenses) | -0.56 | -0.56 | -0.54 | -0.48 | -1.46 | -0.26 |
Pretax Income | -69.09 | -60.03 | 17.05 | -47 | -39.3 | -13.09 |
Income Tax Expense | 84.28 | 79.93 | 8.09 | -8.89 | -6.3 | -1.88 |
Earnings From Continuing Operations | - | -139.96 | 8.96 | -38.11 | -33 | -11.21 |
Net Income to Company | - | -139.96 | 8.96 | -38.11 | -33 | -11.21 |
Net Income | -153.37 | -139.96 | 8.96 | -38.11 | -33 | -11.21 |
Net Income to Common | -153.37 | -139.96 | 8.96 | -38.11 | -33 | -11.21 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 115 | 105 | 105 | 104 | 104 | 98 |
Shares Outstanding (Diluted) | 115 | 105 | 111 | 104 | 104 | 98 |
Shares Change | 12.16% | -5.38% | 6.67% | 0.33% | 5.74% | 10.18% |
EPS (Basic) | -1.34 | -1.33 | 0.09 | -0.37 | -0.32 | -0.11 |
EPS (Diluted) | -1.34 | -1.33 | 0.08 | -0.37 | -0.32 | -0.11 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -22.9 | 5.96 | -10.61 | -38.61 | -17.34 | -10.82 |
Free Cash Flow Per Share | -0.20 | 0.06 | -0.10 | -0.37 | -0.17 | -0.11 |
Gross Margin | -6.20% | 10.73% | 33.40% | -17.90% | -20.63% | 6.94% |
Operating Margin | -82.63% | -46.63% | 3.57% | -73.02% | -80.92% | -20.40% |
Profit Margin | -191.97% | -138.16% | 6.79% | -55.79% | -63.38% | -20.54% |
Free Cash Flow Margin | -28.66% | 5.89% | -8.04% | -56.52% | -33.31% | -19.82% |
EBITDA | -64.18 | -45.52 | 7.18 | -49.19 | -41.62 | -10.76 |
EBITDA Margin | -80.34% | -44.94% | 5.44% | -72.00% | -79.94% | -19.71% |
D&A For EBITDA | 1.83 | 1.72 | 2.47 | 0.69 | 0.51 | 0.38 |
EBIT | -66.01 | -47.24 | 4.71 | -49.89 | -42.13 | -11.14 |
EBIT Margin | -82.63% | -46.63% | 3.57% | -73.02% | -80.92% | -20.40% |
Effective Tax Rate | - | - | 47.44% | - | - | - |
Revenue as Reported | 80.72 | 102.74 | 133.34 | 69.63 | 52.06 | 63.04 |